Trident Texofab Ltd
BSE: 540726
P/L Snapshot
Q1 FY27 · standalone
vs Q4 FY26·vs Q1 FY26
Revenue
26.33
-22.8%-7.7%
Expenditure
25.64
-27.6%-5.5%
Net Profit
0.52
+126.0%-48.7%
OPM %
5.47%
+11.77pp-1.88pp
Shareholding
Pattern breakdown
P/L Trends
(in crores)
RevenueExpenditureNet Profit
Price Chart
Latest News
Corporate Events
Board MeetingTTFL
20267Sep
Board Meeting
The Board of Directors considered and approved the Board's R…
BSE Filing ↗ Board MeetingTTFL
202610Aug
Board Meeting
The board meeting is scheduled to consider and approve the u…
BSE Filing ↗ Board MeetingTTFL
20262Jul
Board Meeting
The Board of Directors considered and approved the forfeitur…
BSE Filing ↗ Board MeetingTTFL
202628May
Board Meeting
To consider and approve the Audited Standalone Financial Res…
BSE Filing ↗ Board MeetingTTFL
202423Oct
Board Meeting
Increase Authorized Share Capital, Consider and Evaluate Pro…
BSE Filing ↗ Board MeetingTTFL
202412Oct
Board Meeting
Consider And Approve The Unaudited Standalone Financial Resu…
BSE Filing ↗ Board MeetingTTFL
202418Jul
Board Meeting
Un-Audited Standalone Financial Results of the Company for t…
BSE Filing ↗ Board MeetingTTFL
202421May
Board Meeting
Consider and approve Audited Standalone Financial Result for…
BSE Filing ↗